🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
0.4205
-0.0026 (-0.61%)
At close: Nov 18, 2026, 4:00 PM EST
0.4500
+0.0295 (7.02%)
After-hours: Nov 18, 2026, 7:30 PM EST

Telomir Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3146123---
Market Cap Growth
-35.64%-62.70%----
Enterprise Value
2738122---
Last Close Price
0.421.334.12---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
6.577.73190.63---
P/TBV Ratio
7.037.73190.63---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.020.080.140.18-0.62-0.86
Net Debt / Equity Ratio
-1.01-1.15-1.820.18-0.62-0.86
Quick Ratio
19.075.101.860.000.00-
Current Ratio
19.615.141.940.330.05-
Return on Equity (ROE)
-96.26%-317.65%-810.18%-1045.36%--
Return on Assets (ROA)
-59.01%-152.03%-250.96%-102.18%--
Return on Capital Employed (ROCE)
-129.10%-178.20%-1903.80%-114.70%91.10%100.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-248.04%-22.77%-13.49%---
Buyback Yield / Dilution
-61.15%-7.16%-8.18%-1.77%--
SEC Filings: 10-K · 10-Q